Dianthus Therapeutics Inc... (DNTH)

NASDAQ: DNTH · Real-Time Price · USD

21.93

0.08 (0.37%)

At close: May 01, 2025, 3:41 PM

Dianthus Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	6.24M	2.83M	6.42M	1.48M	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	355K	147K	2.02M	1.98M	1.84M	875K	376K	6K
Gross Profit	6.24M	2.47M	6.27M	-544K	-1.98M	-1.84M	-875K	-376K	-6K
Operating Income	-101.86M	-48.17M	-29.7M	-13.09M	-78.7M	-82.97M	-59.96M	-35.73M	-9.27M
Interest Income	17.36M	4.76M	1.15M	3K	3.77M	n/a	2.45M	236K	n/a
Pretax Income	-84.97M	-43.55M	-28.48M	-13.11M	-74.94M	-76.77M	-57.52M	-35.49M	-9.43M
Net Income	-84.97M	-43.55M	-28.48M	-13.11M	-74.94M	-76.77M	-57.52M	-35.49M	-9.43M
Selling & General & Admin	24.99M	18.16M	6.74M	1.96M	28.09M	23.76M	17.75M	7.45M	3.48M
Research & Development	83.11M	32.84M	29.38M	12.61M	48.64M	57.37M	41.34M	27.9M	5.78M
Other Expenses	n/a	n/a	-52K	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	108.1M	51M	36.12M	14.56M	76.72M	81.13M	59.09M	35.35M	9.26M
Interest Expense	n/a	n/a	n/a	3.56M	3.77M	n/a	n/a	n/a	163K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	-875K	-376K	-6K
Cost & Expenses	108.1M	51M	36.12M	14.56M	78.7M	82.97M	59.96M	35.73M	9.27M
Income Tax Expense	n/a	n/a	-1.28M	-2M	7.53M	6.2M	2.45M	236K	n/a
Shares Outstanding (Basic)	34.24M	5.15M	3.75M	3.43M	2.75M	2.31M	1.15M	2.21M	2.21M
Shares Outstanding (Diluted)	34.24M	5.15M	3.75M	3.43M	2.75M	2.31M	1.15M	2.21M	2.21M
EPS (Basic)	-2.48	-8.45	-7.6	-3.82	-27.3	-33.18	-27.62	-16.05	-4.27
EPS (Diluted)	-2.48	-8.45	-7.6	-3.82	-27.3	-33.18	-27.62	-16.05	-4.27
EBITDA	-101.86M	-48.17M	-29.56M	-13.09M	-72.96M	-74.93M	-56.64M	-35.12M	-9.26M
EBIT	-101.86M	-48.17M	-29.7M	-13.09M	-74.94M	-76.77M	-57.52M	-35.49M	-9.27M
Depreciation & Amortization	n/a	355K	147K	2.02M	1.98M	1.84M	875K	376K	6K